Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles

Creative Commons License

DERMAN S., MUSTAFAEVA Z. A., ABAMOR E. Ş., BAĞIROVA M., ALLAHVERDİYEV A.

JOURNAL OF BIOMEDICAL SCIENCE, cilt.22, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1186/s12929-015-0195-2
  • Dergi Adı: JOURNAL OF BIOMEDICAL SCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Canine Parvovirus, Vaccine, Antigen, Peptide, PLGA, Nanoparticle, Antigen delivery, CO-GLYCOLIC ACID, IMMUNE-RESPONSES, NITRIC-OXIDE, IN-VITRO, DELIVERY-SYSTEMS, VACCINE DELIVERY, DENDRITIC CELLS, CELLULAR UPTAKE, DRUG-DELIVERY, ANTIGEN
  • Yıldız Teknik Üniversitesi Adresli: Evet

Özet

Background: Canine parvovirus 2 (CPV-2) remains a significant worldwide canine pathogen and the most common cause of viral enteritis in dogs. The 1 L15 and 7 L15 peptides overlap each other with QPDGGQPAV residues (7-15 of VP2 capsid protein of CPV) is shown to produce high immune response. PLGA nanoparticles were demonstrated to have special properties such as; controlled antigen release, protection from degradation, elimination of booster-dose and enhancing the cellular uptake by antigen presenting cells. Nevertheless, there is no study available in literature, about developing vaccine based on PLGA nanoparticles with adjuvant properties against CPV. Thus, the aim of the present study was to synthesize and characterize high immunogenic W-1 L19 peptide (from the VP2 capsid protein of CPV) loaded PLGA nanoparticle and to evaluate their in vitro immunogenic activity.